Development of a Radiomic-Based Model Predicting Lymph Node Involvement in Prostate Cancer Patients
Authors:
- Vincent BourbonneVBVincent Bourbonne
- Vincent JaouenVJVincent Jaouen
- Truong An NguyenTNTruong An Nguyen
- Valentin TissotVTValentin Tissot
- Laurent DoucetLDLaurent Doucet
- Mathieu HattMHMathieu Hatt
- Dimitris VisvikisDVDimitris Visvikis
- Olivier PradierOPOlivier Pradier
- Antoine ValériAVAntoine Valéri
- Georges FournierGFGeorges Fournier
- Ulrike SchickUSUlrike Schick
Open Access
Abstract
Significant advances in lymph node involvement (LNI) risk modeling in prostate cancer (PCa) have been achieved with the addition of visual interpretation of magnetic resonance imaging (MRI) data, but it is likely that quantitative analysis could further improve prediction models. In this study, we aimed to develop and internally validate a novel LNI risk prediction model based on radiomic features extracted from preoperative multimodal MRI. All patients who underwent a preoperative MRI and radical prostatectomy with extensive lymph node dissection were retrospectively included in a single institution. Patients were randomly divided into the training (60%) and testing (40%) sets. Radiomic features were extracted from the index tumor volumes, delineated on the apparent diffusion coefficient corrected map and the T2 sequences. A ComBat harmonization method was applied to account for inter-site heterogeneity. A prediction model was trained using a neural network approach (Multilayer Perceptron Network, SPSS v24.0©) combining clinical, radiomic and all features. It was then evaluated on the testing set and compared to the current available models using the Receiver Operative Characteristics and the C-Index. Two hundred and eighty patients were included, with a median age of 65.2 y (45.3–79.6), a mean PSA level of 9.5 ng/mL (1.04–63.0) and 79.6% of ISUP ≥ 2 tumors. LNI occurred in 51 patients (18.2%), with a median number of extracted nodes of 15 (10–19). In the testing set, with their respective cutoffs applied, the Partin, Roach, Yale, MSKCC, Briganti 2012 and 2017 models resulted in a C-Index of 0.71, 0.66, 0.55, 0.67, 0.65 and 0.73, respectively, while our proposed combined model resulted in a C-Index of 0.89 in the testing set. Radiomic features extracted from the preoperative MRI scans and combined with clinical features through a neural network seem to provide added predictive performance compared to state of the art models regarding LNI risk prediction in PCa.Keywords
This publication has 35 references indexed in Scilit:
- Contemporary Role of the Decipher® Test in Prostate Cancer Management: Current Practice and Future Perspectives.2016
- Haralick texture analysis of prostate MRI: utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scoresEuropean Radiology, 2015
- Selecting the Optimal Candidate for Adjuvant Radiotherapy After Radical Prostatectomy for Prostate Cancer: A Long-term Survival AnalysisEuropean Urology, 2013
- Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection: The Essential Importance of Percentage of Positive CoresEuropean Urology, 2012
- Extent of Pelvic Lymph Node Dissection and the Impact of Standard Template Dissection on Nomogram Prediction of Lymph Node InvolvementEuropean Urology, 2011
- A New Formula for Prostate Cancer Lymph Node RiskInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Anatomical Extent of Pelvic Lymphadenectomy in Patients Undergoing Radical ProstatectomyEuropean Urology, 2007
- Complications and Other Surgical Outcomes Associated with Extended Pelvic Lymphadenectomy in Men with Localized Prostate CancerEuropean Urology, 2006
- Adjusting batch effects in microarray expression data using empirical Bayes methodsBiostatistics, 2006
- Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and gleason score in men with clinically localized prostate cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1994